Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stromal cell therapy in patients with heart failure
2008-001850-42Phase 2Completed
- Sponsor
- The Heart Centre, Rigshospitalet
- Start
- May 2008
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of Provacel in heart failure (HF) (2 arms), sponsored by The Heart Centre, Rigshospitalet. Primary endpoint: Clinical and left ventricular function. Started May 2008; status: completed.
02
Drugs
Provacel
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-001850-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001850-42.